You are here

  • Home
  • Archive
  • Volume 74, Issue Suppl 2
  • OP0018 Pregnancy Outcomes with Trimesters of Maternal Exposure to Certolizumab Pegol: Prospective and Retrospective Reports from Safety Surveillance

Article metrics

Article menu
Download PDFPDF
Oral Presentations
Pregnancy in rheumatic disease
OP0018 Pregnancy Outcomes with Trimesters of Maternal Exposure to Certolizumab Pegol: Prospective and Retrospective Reports from Safety Surveillance

 

Online download statistics by month:

Online download statistics by month: June 2015 to March 2024

AbstractFullPdf
Jun 20153700
Jul 20152704
Aug 20152405
Sep 20156101
Oct 20151301
Nov 20151002
Dec 20151300
Jan 20161904
Feb 20161601
Mar 20162107
Apr 20163808
May 20162703
Jun 20161501
Jul 201625019
Aug 20162002
Sep 20164206
Oct 20161605
Nov 20161503
Dec 20162202
Jan 20171601
Feb 20171500
Mar 201716001
Apr 20179300
May 2017702
Jun 20174705
Jul 20173002
Aug 20173201
Sep 20171801
Oct 20171400
Nov 20172601
Dec 20171001
Jan 20181201
Feb 2018600
Mar 20183201
Apr 20181600
May 20182401
Jun 20183402
Jul 20181400
Aug 20181801
Sep 20182803
Oct 2018400
Nov 20181400
Dec 20181400
Jan 20191401
Feb 2019400
Mar 2019701
Apr 2019800
May 2019801
Jun 2019200
Jul 2019800
Aug 20191200
Sep 20191400
Oct 2019501
Nov 20191001
Dec 2019400
Jan 2020200
Feb 2020400
Mar 2020300
Apr 20201602
May 20201600
Jun 20201200
Jul 20201401
Aug 2020900
Sep 20203000
Oct 20201200
Nov 20202300
Dec 2020400
Jan 20211400
Feb 2021200
Mar 2021500
Apr 2021500
Aug 2021001
Oct 20211401
Nov 20212100
Dec 20211000
Jan 2022600
Feb 20222600
Mar 2022500
Apr 20221600
May 20221200
Jun 2022400
Jul 2022400
Aug 2022800
Sep 2022600
Oct 2022600
Nov 2022600
Dec 2022800
Jan 2023600
Feb 2023600
Mar 2023700
Apr 2023500
May 20231000
Jul 2023401
Aug 2023200
Sep 2023601
Oct 2023400
Dec 20231600
Jan 2024200
Feb 20242400
Mar 2024500
Total16610110